Seeking Alpha

Jazz Pharmaceuticals (JAZZ -0.4%) says regulators have given final approval to a generic version...

Jazz Pharmaceuticals (JAZZ -0.4%) says regulators have given final approval to a generic version of the company's Luvox CR anti-depressant by Par Pharmaceutical. Additionally, Kohlberg Kravis Roberts (KKR) confirnms that it sold around 3.73M shares late last week at $58.28 each for $218.5M in gross proceeds, reducing its stake to around 6.5%.
From other sites
Comments (1)
  • miriam64
    , contributor
    Comments (8) | Send Message
     
    What % of Jazz sales does Luvox represent
    14 Mar 2013, 02:43 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs